BACTERIAL COLONY GROWTH IN THE VENTILATOR CIRCUIT OF THE INTENSIVE OBSERVATION UNIT AT RSUD Dr. SOETOMO SURABAYA
Downloads
Ventilator-associated pneumonia (VAP) remains a problem with the highest cos, morbidity and mortalityt in the Intensive Care Unit (ICU). The correlation between mechanical ventilation and pneumonia is considered as common sense, yet scientific evidence to support this statement is still needed. This research aims to analyze the bacterial colony grows in mechanical ventilation circuit and those grew in the patient's sputum culture. We performed an observational study. Samples for bacterial culture were taken from ventilator circuit and patient sputum on Day-0, Day-3 and Day-7. Sputum samplings are collected using double catheter tracheal aspiration technique; Results are then analyzed with Chi-square test. While the similarity of bacteria species in ventilator circuit to patient's sputum is analyzed with Binomial test. Two samples are dropped out immediately due to the rate of bacterial growth on Day-0. Bacterial colony growth in ventilator circuit shows a significant difference on Day-3 and Day-7 at 50% and 92% respectively (p = 0.05). A comparison for the bacterial similarity of the ventilator circuit and patient's sputum shows that the bacterial growth on Day-3 is 7 out of 14 (50%) and 3 with more than 105 CFU/ml colony; while on Day-7, there are 13 out of 14 positive bacterial growth, both in the circuit and the patient's sputum. Among them, 5 out of 14 (35%) of the bacterial colony which grow in the circuit have the same species as those grow in patient's sputum. The recent study shows that there is bacteria colony growth in the ventilator circuit after Day-3 and a significant increase on Day-7. Almost half of the colony illustrates similar species from both ventilator circuit and patient's sputum. This suggests that the bacterial growth on Day-7 in the ventilator circuit might be related to those growth in patient's sputum.
Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilatorassociated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005 Jun;50(6):725-39-41.
Hooser T Van. Ventilator-Associated Pneumonia ( VAP ) Best Practice Strategies for Caregivers By D . Theron Van Hooser. Kimberly-Clark Heal Care. 2002;
Kollef MH. The Prevention of Ventilator-Associated Pneumonia. N Engl J Med. 1999 Feb 25;340(8):627–34.
Wiryana M. VENTILATOR ASSOCIATED PNEUMONIA. J Penyakit Dalam. 2007 Sep;8(3):1–15.
Branson RD. The ventilator circuit and ventilator-associated pneumonia. Respir Care. 2005 Jun;50(6):774-87-7.
Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL, et al. Care of the ventilator circuit and its relation to ventilator-associated pneumonia. Respir Care. 2003 Sep;48(9):869–79.
Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 1986 May;133(5):792–6.
Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002 Apr 1;165(7):867–903.
Garibaldi RA, Britt MR, Coleman ML, Reading JC, Pace NL. Risk factors for postoperative pneumonia. Am J Med. 1981 Mar;70(3):677–80.
Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilatorassociated pneumonia. Chest. 1993 Oct;104(4):1230–5.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
